Proteomic pattern analysis discriminates among multiple sclerosis–related disorders

Abstract

Our findings suggest that CSF proteomic pattern analysis can increase the accuracy of disease diagnosis of MS-related disorders and will aid physicians in appropriate therapeutic decision-making.